Skip to content

JSPR

Jasper Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.63
−0.65%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 9, 2026
EPS estimate
-$0.08
Revenue estimate
$12.0M

Latest reported

Last report date
Aug 14, 2026
EPS actual
-$0.10
EPS estimate
-$0.27
Revenue actual
Revenue estimate

Track record

Trailing twelve quarters

EPS beats (12Q)
6
EPS misses (12Q)
6
EPS in line (12Q)
0
Avg surprise (4Q)
+23.6%
Revenue beats (12Q)
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 14, 2026-$0.27-$0.10Beat 62.66%
May 14, 2026-$0.46-$0.38Beat 17.39%
Mar 30, 2026-$0.79-$0.32Beat 59.49%
Aug 13, 2025-$1.20-$1.74Miss -45.00%
Feb 27, 2025-$1.27-$1.62Miss -27.56%$1.2M
Nov 7, 2024-$1.09-$1.24Miss -13.76%
Mar 4, 2024-$1.65-$1.50Beat 9.09%$2.1M
Nov 9, 2023-$1.50-$1.60Miss -6.67%
Aug 11, 2023-$1.30-$1.50Miss -15.38%
May 12, 2023-$1.50-$1.60Miss -6.67%
Mar 8, 2023-$3.70-$3.60Beat 2.70%
Nov 10, 2022-$3.50-$3.20Beat 8.57%

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026